Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thioguanine exposure during pregnancy in women with inflammatory bowel disease
NL-OMON26685Recruiting
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tioguanine in Crohn's disease, autoimmune colitis and inflammatory bowel disease (IBD), sponsored by None. Primary endpoints: Birth defects, Preterm birth rate and 3 more. Started Dec 2018; status: recruiting.
02
Drugs
tioguanine
03
Conditions
Crohn's diseaseautoimmune colitisinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NL-OMON26685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26685.